# Triferic AVNU Infusion Via Freedom Pump During Hemodialysis

> **NCT04689932** · PHASE4 · COMPLETED · sponsor: **Rockwell Medical Technologies, Inc.** · enrollment: 12 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** Triferic AVNU

## Key facts

- **NCT ID:** NCT04689932
- **Lead sponsor:** Rockwell Medical Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-19
- **Primary completion:** 2021-06-19
- **Final completion:** 2021-06-19
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04689932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04689932, "Triferic AVNU Infusion Via Freedom Pump During Hemodialysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04689932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*